Last edition
News about "First-in-Human Trial"
Infinitopes Raises USD 35.1 Million to Advance Precision Cancer Vaccine into First-in-Human Trial
Infinitopes, a clinical-stage biotechnology company developing cancer vaccines, has completed the second close of its seed financing round, raising an additional USD 15.4 million and bringing total funds secured to USD 35.1 million.
First-in-Human Trial | 21/01/2026 | By Darshana
Rondo Therapeutics Begins First-in-Human Trial of Novel CD28 - Nectin-4 Bispecific for Solid Tumours
Rondo Therapeutics, a clinical-stage biopharmaceutical company developing next-generation T-cell engaging bispecific antibodies for solid tumours, has begun dosing patients in its phase 1/1b clinical trial of RNDO-564.
First-in-Human Trial | 07/12/2025 | By Darshana | 147
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy